Cadrenal Therapeutics, Inc. Common Stock Defensive Interval Ratio
Cadrenal Therapeutics, Inc. Common Stock defensive interval ratio. Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a Defensive Interval Ratio of 2 days as of March 2026. Defensive assets of $5.47K (cash $-, short-term investments $-, receivables $5.47K) cover 2 days of daily cash needs of $2.92K/day. See working capital position of Cadrenal Therapeutics, Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Cadrenal Therapeutics, Inc. Common Stock (2024–2025)
Defensive interval ratio of Cadrenal Therapeutics, Inc. Common Stock from 2024 to 2025. This chart shows how Cadrenal Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the ratio stands at 2 days, meaning defensive assets of $5.47K can fund 2 days of operations without new revenue. Read total liabilities of Cadrenal Therapeutics, Inc. Common Stock for a breakdown of total debt and financial obligations.
Cadrenal Therapeutics, Inc. Common Stock Defensive Interval Ratio by Year (2024–2025)
Cadrenal Therapeutics, Inc. Common Stock defensive interval ratio by year from 2024 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Cadrenal Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see CVKD total asset value.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1 days | $5.10K | $4.35K/day | $- | $- | ▼ -4 days |
| 2024 | 5 days | $38.15K | $7.35K/day | $- | $- | — |